WHO Awards Prequalification to Roche's HPV Test for Broad Use, Enhancing Global Cervical Cancer Screening

The World Health Organization (WHO) has awarded Roche's human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System ...

June 27, 2024 | Thursday | News
Metabolon Secures NIH Grant to Develop Innovative Monitoring Tool for Type 1 Diabetes Progression

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic develop...

June 26, 2024 | Wednesday | News
ANEW Medical Explores Pioneering Therapeutics and Diagnostics with Secreted Klotho Proteins

ANEW to explore therapeutics and specialty diagnostics utilizing the s-KL protein and will pursue other medical product development and commercial oppo...

June 26, 2024 | Wednesday | News
Junshi Biosciences' Toripalimab Approved in China for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer

Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of nov...

June 18, 2024 | Tuesday | News
LIXTE Biotechnology Announces Clinical Trial Collaboration with Roche and NKI for MSI Low Metastatic Colon Cancer

LIXTE Biotechnology Holdings, Inc.  a clinical stage pharmaceutical company, today announced a collaboration with Roche and the Netherlands Cancer I...

June 17, 2024 | Monday | News
UCB Presents Promising Data on Certolizumab Pegol for Pregnant Women and High RF RA Patients at EULAR 2024

  Pharmacokinetic data from the CHERISH study suggest that pregnant women treated with certolizumab pegol can maintain their do...

June 17, 2024 | Monday | News
Biosplice Therapeutics and Novo Nordisk Partner to Develop Innovative Diabetes Treatments Targeting DYRK Inhibition

  Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on smal...

June 13, 2024 | Thursday | News
Global Cancer Cases Set to Surge to 32 Million Annually by 2050, with Dramatic Increases in Low-Income Countries

Cancer incidence is expected to rise significantly through 2050, particularly in lower-income countries, to 32 million new cases annually – a pot...

June 11, 2024 | Tuesday | Reports
Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence T...

June 11, 2024 | Tuesday | News
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients

NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, a...

June 11, 2024 | Tuesday | News
FDA Accepts Eisai and Biogen’s Application for Monthly Maintenance Dosing of Alzheimer's Drug LEQEMBI

Eisai Co.,  and Biogen announced that the U.S. Food and Drug Administration (FDA) has accepted Eisai’s Supplemental Biologics License Applicat...

June 10, 2024 | Monday | News
QIAGEN Launches Enhanced QIAstat-Dx Respiratory Panel in Malaysia, Now Detects 23 Pathogens Including Chlamydophila pneumoniae

The CE-IVD marked QIAstat-Dx Respiratory SARS-CoV-2 Panel is available in Malaysia  expanded to 23 pathogens, now includes Chlamydophila pneumoniae&nb...

June 05, 2024 | Wednesday | News
EU Committee Recommends Dupixent as Breakthrough Therapy for Uncontrolled COPD with Raised Blood Eosinophilsv

Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent sign...

May 31, 2024 | Friday | News
Stryker Introduces Gamma4 Hip Fracture Nailing System in Europe, Transforming Surgical Treatment

Stryker a global leader in medical technologies, announced that the first surgeries using the Gamma4 Hip Fracture Nailing System in Europe were completed...

May 29, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close